(Q44649327)

5 December 2017

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). (English)

1 reference

5 December 2017

5

Klaus-Armin Nave

1 reference

5 December 2017

2

Gerd Meyer zu Hörste

1 reference

5 December 2017

3

Ueli Suter

1 reference

5 December 2017

Michael W Sereda

1

1 reference

PubMed ID

14608378

5 December 2017

Naureen Uzma

series ordinal

4

1 reference

PubMed ID

14608378

5 December 2017

language of work or name

English

0 references

publication date

9 November 2003

1 reference

5 December 2017

1 reference

5 December 2017

9

1 reference

5 December 2017

1533-1537

1 reference

5 December 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nm957

5 December 2017

0 references

cites work

Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation

1 reference

Molecular cell biology of Charcot-Marie-Tooth disease.

21 January 2018

1 reference

The phenotypic manifestations of chromosome 17p11.2 duplication.

21 January 2018

1 reference

Progesterone as a neurosteroid: synthesis and actions in rat glial cells

21 January 2018

1 reference

The transcriptional basis of steroid physiology

21 January 2018

1 reference

Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells

21 January 2018

1 reference

Progesterone receptor and the mechanism of action of progesterone antagonists

21 January 2018

1 reference

Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat.

21 January 2018

1 reference

Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA.

21 January 2018

1 reference

Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.

21 January 2018

1 reference

Progesterone stimulates Krox-20 gene expression in Schwann cells.

21 January 2018

1 reference

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer

21 January 2018

1 reference

Effects of an antiprogestin onapristone on the endometrium of bonnet monkeys: morphometric and ultrastructural studies

21 January 2018

1 reference

Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)

21 January 2018

1 reference

DNA duplication associated with Charcot-Marie-Tooth disease type 1A

21 January 2018

1 reference

7 January 2021

A transgenic rat model of Charcot-Marie-Tooth disease

1 reference

7 January 2021

Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication

1 reference

7 January 2021

Progesterone synthesis and myelin formation by Schwann cells

1 reference

7 January 2021

Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells.

1 reference

7 January 2021

Progesterone synthesis and myelin formation in peripheral nerves

1 reference

7 January 2021

Antiprogestin-progesterone interactions.

1 reference

7 January 2021

Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage

1 reference

7 January 2021

Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22

1 reference

7 January 2021

Exacerbation of Charcot-Marie-tooth disease in pregnancy

1 reference

7 January 2021

Pregnancy and delivery in Charcot-Marie-Tooth disease type 1

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM957

1 reference

5 December 2017

1 reference

PubMed ID

14608378